A combined carrier-adjuvant system of peptide nanofibers and toll-like receptor agonists potentiates robust CD8+ T cell responses. [electronic resource]
- Vaccine 01 2018
- 438-441 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural